Role of natural compounds in non-alcoholic fatty liver diseases (NAFLD): a mechanistic approach

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Egyptian Liver Journal

• Publication date

  2025-08-26

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1186/s43066-025-00452-w
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Spirulina Supplementation Alleviates Intense Exercise-Induced Damage and Modulates Gut Microbiota in Mice

  2025cited by this paper
• The Effect of Eight Weeks of Aerobic Exercise and Spirulina Supplementation on Some Liver Enzymes, Body Composition, and Cardiorespiratory Fitness in Overweight and Obese Adult Women

  2025cited by this paper
• The Detoxifying Effects of Spirulina in Promoting Liver Health and Heavy Metal Elimination – A Review

  2025cited by this paper
• Impact of Silymarin Supplementation on Liver Function and Enzyme Profiles in Diverse Chronic Liver Disease Etiologies

  2024cited by this paper
• Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice

  2024cited by this paper
• Chronic exercise improves hepatic acylcarnitine handling

  2024cited by this paper
• Astaxanthin Rescues Memory Impairments in Rats with Vascular Dementia by Protecting Against Neuronal Death in the Hippocampus

  2024cited by this paper
• A Descriptive Review of the Antioxidant Effects and Mechanisms of Action of Berberine and Silymarin

  2024cited by this paper
• Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cited by this paper
• Changes in nonalcoholic fatty liver disease and M2BPGi due to lifestyle intervention in primary healthcare

  2024cited by this paper
• Silymarin as an Antioxidant Therapy in Chronic Liver Diseases: A Comprehensive Review

  2024cited by this paper
• Development of a reference and proficiency chemical list for human steatosis endpoints in vitro

  2023cited by this paper
• Dietary strategies in non‐alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review

  2023cited by this paper
• Silymarin and management of liver function in non-alcoholic steatohepatitis: a case report

  2023cited by this paper
• Preventative and Therapeutic Effects of Astaxanthin on NAFLD

  2023cited by this paper
• Changing epidemiology, global trends and implications for outcomes of NAFLD.

  2023cited by this paper
• Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review

  2023cited by this paper
• Impact of Silymarin Supplements on Liver Enzyme Levels: A Systematic Review

  2023cited by this paper
• The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

  2023cited by this paper
• Chromatographic Analyses of Spirulina (Arthrospira platensis) and Mechanism of Its Protective Effects against Experimental Obesity and Hepatic Steatosis in Rats

  2023cited by this paper
• Omega-3 intake is associated with liver disease protection

  2023cited by this paper
• Hepatitis C and Nonalcoholic Steatohepatitis in the 21st Century: Impact on Liver Disease and Liver Transplantation

  2023cited by this paper
• Robotic versus laparoscopic revisional bariatric surgeries: a systematic review and meta-analysis

  2023cited by this paper
• Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments

  2022cited by this paper
• The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications

  2022cited by this paper
• Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis

  2022cited by this paper
• Six Types of Tea Reduce Acute Alcoholism in Mice by Enhancing Ethanol Metabolism, Suppressing Oxidative Stress and Inflammation

  2022cited by this paper
• Salubrious Effects of Green Tea Catechins on Fatty Liver Disease: A Systematic Review

  2022cited by this paper
• Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease

  2022cited by this paper
• Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.

  2022cited by this paper
• Berberine alleviates non-alcoholic hepatic steatosis partially by promoting SIRT1 deacetylation of CPT1A in mice

  2022cited by this paper
• Ferulic Acid and P-Coumaric Acid Synergistically Attenuate Non-Alcoholic Fatty Liver Disease through HDAC1/PPARG-Mediated Free Fatty Acid Uptake

  2022cited by this paper
• SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease

  2021cited by this paper
• Mechanisms of protective effects of astaxanthin in nonalcoholic fatty liver disease

  2021cited by this paper
• Treatments for NAFLD: State of Art

  2021cited by this paper
• Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH

  2021cited by this paper
• Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease

  2021cited by this paper
• Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis

  2021cited by this paper
• Green tea and selenium-enriched green tea ameliorates non-alcoholic fatty liver disease through peripheral 5-hydroxytryptamine signals in high-fat diet-fed mice

  2021cited by this paper
• Variations of Serum Oxidative Stress Biomarkers under First-Line Antituberculosis Treatment: A Pilot Study

  2021cited by this paper
• Recent advances of electrochemical sensors for detecting and monitoring ROS/RNS.

  2021cited by this paper
• Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy

  2021cited by this paper
• PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS.

  2021cited by this paper
• Insulin Resistance: From Mechanisms to Therapeutic Strategies

  2021cited by this paper
• Dietary carbohydrates and fats in nonalcoholic fatty liver disease

  2021cited by this paper
• Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications

  2021cited by this paper
• Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides

  2021cited by this paper
• Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease

  2021cited by this paper
• Molecular aspects of fructose metabolism and metabolic disease.

  2021cited by this paper
• How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?

  2021cited by this paper
• The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease

  2021cited by this paper
• Silymarin attenuated nonalcoholic fatty liver disease through the regulation of endoplasmic reticulum stress proteins GRP78 and XBP-1 in mice.

  2020cited by this paper
• Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non‐alcoholic fatty liver disease by up‐regulating the FGF21/PGC‐1α pathway

  2020cited by this paper
• Epidemiological Features of NAFLD From 1999 to 2018 in China

  2020cited by this paper
• Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta‐analysis of randomized clinical trials

  2020cited by this paper
• Effect of Astaxanthin on the Expression and Activity of Aquaporin-3 in Skin in an In-Vitro Study

  2020cited by this paper
• Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping.

  2020cited by this paper
• S-petasin inhibits lipid accumulation in oleic acid-induced HepG2 cells through activation of the AMPK signaling pathway.

  2020cited by this paper
• The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease

  2020cited by this paper
• Mitochondrial dysfunction in fibrotic diseases

  2020cited by this paper
• Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD

  2020cited by this paper
• The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)

  2020cited by this paper
• Autophagy and Redox Homeostasis in Parkinson's: A Crucial Balancing Act

  2020cited by this paper
• The effectiveness and safety of curcumin as a complementary therapy in inflammatory bowel disease: a protocol of systematic review and meta-analysis

  2020cited by this paper
• Metabolic outcomes after revisional bariatric surgery: a systematic review and meta-analysis.

  2020cited by this paper
• Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping

  2020cited by this paper
• The role of nutrition in non‐alcoholic fatty liver disease: Pathophysiology and management

  2020cited by this paper
• Gut-Liver Axis Modulation: A Potential Role of Probiotics and Omega-3 Fatty Acids in Management of NAFLD

  2020cited by this paper
• Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies.

  2020cited by this paper
• HISTOPATHOLOGICAL STUDY OF THE PROTECTIVE EFFECT OF SPIRULINA PLATENSIS ON FETAL LIVER OF MICE WITH ACUTE FATTY LIVER OF PREGNANCY

  2020cited by this paper
• New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress

  2020cited by this paper
• Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD

  2019cited by this paper
• Drug discovery and treatment paradigms in nonalcoholic steatohepatitis

  2019cited by this paper
• Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

  2019cited by this paper
• Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?

  2019cited by this paper
• Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.

  2019cited by this paper
• Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction

  2019cited by this paper
• Nutrition and Wound Healing: An Overview Focusing on the Beneficial Effects of Curcumin

  2019cited by this paper
• Olive oil antioxidants and non-alcoholic fatty liver disease

  2019cited by this paper
• miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease

  2019cited by this paper
• Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice

  2019cited by this paper
• The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials

  2019cited by this paper
• The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine

  2018cited by this paper
• Evaluation of a High Concentrate Omega-3 for Correcting the Omega-3 Fatty Acid Nutritional Deficiency in Non-Alcoholic Fatty Liver Disease (CONDIN)

  2018cited by this paper
• The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet

  2018cited by this paper
• Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease

  2018cited by this paper
• Catalase and nonalcoholic fatty liver disease

  2018cited by this paper
• Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft

  2018cited by this paper
• Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders

  2018cited by this paper
• Effect of Green Tea Varnish on Depth of Root Caries.

  2018cited by this paper
• Anti-inflammatory, antioxidant and antihepatotoxic effects of Spirulina platensis against d-galactosamine induced hepatotoxicity in rats

  2018cited by this paper
• Evaluation of a High Concentrate Omega-3 for Correcting the Omega-3 Fatty Acid Nutritional Deficiency in Non-alcoholic Fatty Liver Disease and effects on Hepatic Steatosis (CONDIN)

  2018cited by this paper
• Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action.

  2018cited by this paper
• Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence

  2018cited by this paper
• Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota

  2018cited by this paper
• Dietary Intervention in Clinical Improvement of Nonalcoholic Fatty Liver Patients

  2018cited by this paper
• Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis

  2018cited by this paper
• The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease

  2017cited by this paper
• The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease

  2017cited by this paper
• Hepatic Transcriptome Profiles of Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E

  2017cited by this paper

• Liver fibrosis assessment in rheumatoid arthritis patients on long-term methotrexate therapy using hepatic fibroScan (transient elastography)

  2026cites this paper
• Spirulina supplementation and rheumatoid arthritis: A systematic review of current research and molecular mechanisms

  2025cites this paper
• Anthocyanins Modulation of Gut Microbiota to Reverse Obesity-Driven Inflammation and Insulin Resistance

  2025cites this paper
• Carvacrol-Loaded Chitosan Nanoparticles as a Multifunctional Nanotherapeutic Strategy Targeting Oxidative Stress, Inflammation, Apoptosis, and Genotoxicity in Nonalcoholic Fatty Liver Disease

  2025cites this paper